Citigroup’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.47M Buy
53,202
+20,095
+61% +$556K ﹤0.01% 2273
2025
Q1
$735K Sell
33,107
-28,375
-46% -$630K ﹤0.01% 2736
2024
Q4
$1.22M Buy
61,482
+29,786
+94% +$589K ﹤0.01% 2467
2024
Q3
$792K Buy
31,696
+23,802
+302% +$595K ﹤0.01% 2722
2024
Q2
$147K Sell
7,894
-183,126
-96% -$3.42M ﹤0.01% 3315
2024
Q1
$3.77M Buy
191,020
+144,662
+312% +$2.85M ﹤0.01% 1412
2023
Q4
$813K Sell
46,358
-17,793
-28% -$312K ﹤0.01% 2331
2023
Q3
$1.11M Buy
64,151
+15,825
+33% +$275K ﹤0.01% 1824
2023
Q2
$680K Sell
48,326
-85,035
-64% -$1.2M ﹤0.01% 2520
2023
Q1
$1.43M Buy
133,361
+90,253
+209% +$971K ﹤0.01% 1748
2022
Q4
$646K Buy
43,108
+41,230
+2,195% +$618K ﹤0.01% 2362
2022
Q3
$24K Sell
1,878
-2,763
-60% -$35.3K ﹤0.01% 3955
2022
Q2
$45K Buy
4,641
+1,780
+62% +$17.3K ﹤0.01% 3898
2022
Q1
$29K Sell
2,861
-70,965
-96% -$719K ﹤0.01% 4245
2021
Q4
$869K Buy
73,826
+14,656
+25% +$173K ﹤0.01% 2675
2021
Q3
$674K Sell
59,170
-99,785
-63% -$1.14M ﹤0.01% 2697
2021
Q2
$2.21M Buy
158,955
+21,894
+16% +$305K ﹤0.01% 2030
2021
Q1
$2.54M Buy
137,061
+130,556
+2,007% +$2.42M ﹤0.01% 1791
2020
Q4
$115K Buy
6,505
+4,944
+317% +$87.4K ﹤0.01% 3591
2020
Q3
$24K Sell
1,561
-4,130
-73% -$63.5K ﹤0.01% 3843
2020
Q2
$145K Buy
5,691
+1,745
+44% +$44.5K ﹤0.01% 3243
2020
Q1
$61K Buy
3,946
+1,149
+41% +$17.8K ﹤0.01% 3634
2019
Q4
$31K Buy
2,797
+1,623
+138% +$18K ﹤0.01% 4279
2019
Q3
$10K Sell
1,174
-3,152
-73% -$26.8K ﹤0.01% 4565
2019
Q2
$58K Buy
4,326
+900
+26% +$12.1K ﹤0.01% 3978
2019
Q1
$62K Buy
3,426
+2,033
+146% +$36.8K ﹤0.01% 3885
2018
Q4
$40K Sell
1,393
-492
-26% -$14.1K ﹤0.01% 4054
2018
Q3
$48K Buy
+1,885
New +$48K ﹤0.01% 4096